Cancer Stem Cells in Squamous Cell Carcinoma Switch between Two Distinct Phenotypes That Are Preferentially Migratory or Proliferative
Adrian Biddle,Xiao Liang,Luke Gammon,Bilal Fazil,Lisa J. Harper,Helena Emich,Daniela Elena Costea,Ian C. Mackenzie +7 more
Reads0
Chats0
TLDR
A need to define therapeutic targets that can eradicate both EMT and self-renewing CSC variants to achieve effective SCC treatment is suggested.Abstract:
Epithelial-to-mesenchymal transition (EMT) is an important driver of tumor invasion and metastasis, which causes many cancer deaths. Cancer stem cells (CSC) that maintain and initiate tumors have also been implicated in invasion and metastasis, but whether EMT is an important contributor to CSC function is unclear. In this study, we investigated whether a population of CSCs that have undergone EMT (EMT CSCs) exists in squamous cell carcinoma (SCC). We also determined whether a separate population of CSCs that retain epithelial characteristics (non-EMT CSCs) is also present. Our studies revealed that self-renewing CSCs in SCC include two biologically-distinct phenotypes. One phenotype, termed CD44(high)ESA(high), was proliferative and retained epithelial characteristics (non-EMT CSCs), whereas the other phenotype, termed CD44(high)ESA(low), was migratory and had mesenchymal traits characteristic of EMT CSCs. We found that non-EMT and EMT CSCs could switch their epithelial or mesenchymal traits to reconstitute the cellular heterogeneity which was characteristic of CSCs. However, the ability of EMT CSCs to switch to non-EMT character was restricted to cells that were also ALDH1(+), implying that only ALDH1(+) EMT cells had the ability to seed a new epithelial tumor. Taken together, our findings highlight the identification of two distinct CSC phenotypes and suggest a need to define therapeutic targets that can eradicate both of these variants to achieve effective SCC treatment.read more
Citations
More filters
Journal ArticleDOI
EMT Transition States during Tumor Progression and Metastasis.
TL;DR: The role of the transcriptional and epigenetic landscapes, gene regulatory network and their surrounding niche in controlling the transition through the different EMT states in cancer is summarized.
Journal ArticleDOI
Targeting metastasis-initiating cells through the fatty acid receptor CD36
Gloria Pascual,Alexandra Avgustinova,Stefania Mejetta,Mercè Martín,Andrés Castellanos,Camille Stephan-Otto Attolini,Antoni Berenguer,Neus Prats,Agustí Toll,Juan Antonio Hueto,Coro Bescós,Luciano Di Croce,Luciano Di Croce,Salvador Aznar Benitah +13 more
TL;DR: The results indicate that metastasis-initiating cells particularly rely on dietary lipids to promote metastasis, at least in human melanoma- and breast cancer-derived tumours.
Journal ArticleDOI
Breast cancer stem cells transition between epithelial and mesenchymal states reflective of their normal counterparts
Suling Liu,Yang Cong,Dong Wang,Yu-Min Sun,Lu Deng,Yajing Liu,Rachel Martin-Trevino,Li Shang,Sean P. McDermott,Melissa D. Landis,Su-Hyung Hong,April Adams,Rosemarie C. D'Angelo,Christophe Ginestier,Emmanuelle Charafe-Jauffret,Shawn G. Clouthier,Daniel Birnbaum,Stephen T. C. Wong,Ming Zhan,Jenny C. Chang,Max S. Wicha +20 more
TL;DR: It is proposed that the plasticity of BCSCs that allows them to transition between EMT- and MET-like states endows these cells with the capacity for tissue invasion, dissemination, and growth at metastatic sites.
Journal ArticleDOI
The molecular landscape of head and neck cancer
TL;DR: It became apparent that HNSCC is a disease characterized by frequent mutations that create neoantigens, indicating that immunotherapies might be effective and that immunotherapy trials with immune checkpoint inhibitors were published, and these may be considered as a paradigm shift in head and neck oncology.
Journal ArticleDOI
Implications of the Hybrid Epithelial/Mesenchymal Phenotype in Metastasis
Mohit Kumar Jolly,Marcelo Boareto,Marcelo Boareto,Bin Huang,Dongya Jia,Mingyang Lu,Eshel Ben-Jacob,Eshel Ben-Jacob,José N. Onuchic,Herbert Levine +9 more
TL;DR: The operating principles of the core regulatory network for EMT/MET that acts as a “three-way” switch giving rise to three distinct phenotypes – E, M and hybrid E/M are reviewed and a theoretical framework that can elucidate the role of many other players in regulating epithelial plasticity is presented.
References
More filters
Journal ArticleDOI
The mesenchymal cell, its role in the embryo, and the remarkable signaling mechanisms that create it
TL;DR: The time has come for serious study of the underlying mechanisms and the signaling pathways that are used to form the mesenchymal cell in the embryo, and current understanding of the mechanisms used for EMT in vitro, as well as those that have been implicated in E MT in vivo.
Journal ArticleDOI
Axl is an essential epithelial-to-mesenchymal transition-induced regulator of breast cancer metastasis and patient survival.
Christine Gjerdrum,Crina Tiron,Torill Høiby,Ingunn M. Stefansson,Hallvard Haugen,Tone Sandal,Karin Collett,Shan Li,Emmet McCormack,Bjørn Tore Gjertsen,David Micklem,Lars A. Akslen,Carlotta A. Glackin,James B. Lorens +13 more
TL;DR: It is suggested that Axl represents a downstream effector of the tumor cell EMT that is required for breast cancer metastasis, and the detection and targeted treatment of Axl-expressing tumors represents an important new therapeutic strategy for Breast cancer.
Journal ArticleDOI
Single-marker identification of head and neck squamous cell carcinoma cancer stem cells with aldehyde dehydrogenase.
Matthew R. Clay,Mark H. Tabor,John H. Owen,Thomas E. Carey,Carol R. Bradford,Gregory T. Wolf,Max S. Wicha,Mark E. Prince +7 more
TL;DR: It is reported that CD44 isolates tumorigenic cells from head and neck squamous cell cancer (HNSCC) and recent studies indicate that aldehyde dehydrogenase activity may represent a more specific marker of CSCs.
Journal ArticleDOI
Epithelial-to-mesenchymal transition and integrin-linked kinase mediate sensitivity to epidermal growth factor receptor inhibition in human hepatoma cells.
Bryan C. Fuchs,Tsutomu Fujii,Jon D. Dorfman,Jonathan M. Goodwin,Andrew X. Zhu,Michael Lanuti,Kenneth K. Tanabe +6 more
TL;DR: It is suggested that epithelial-to-mesenchymal transition predicts HCC sensitivity to EGFR-targeted therapies and that ILK is a novel target to overcome HCC resistance to EG FR inhibition.
Journal ArticleDOI
Retention of intrinsic stem cell hierarchies in carcinoma-derived cell lines.
TL;DR: The present observations indicate that stem cell patterns are robust and persist even in cell lines, and an understanding of this behavior should facilitate studies directed towards the molecular or pharmacologic manipulation of malignant stem cell survival.